Strategies to Enhance Integrative Repair of the Meniscus

描述(申请人提供)：半月板是位于股骨髁和胫骨平台之间的纤维软骨组织。这些结构对于膝关节的正常生物力学功能是必不可少的，包括承载、减震、关节一致性和关节稳定性。除了最初的半月板损伤带来的疼痛和残疾外，半月板组织的损伤或丢失还与关节退行性变化有关，最终导致骨关节炎(OA)。在损伤和退变的关节中，检测到炎性细胞因子，如白介素1(IL-1)的水平增加。此外，IL-1还能上调半月板细胞的降解酶，如基质金属蛋白酶(MMPs)，并减少半月板细胞的基质生物合成。在半月板修复模型系统中，IL-1也被证明显著降低修复强度、细胞聚集和界面处的组织形成。然而，IL-1抑制半月板损伤修复的机制(S)尚不清楚。本研究的目的是确定IL-1阻止半月板损伤修复的机制(S)，并开发在存在IL-1的情况下促进半月板损伤愈合的策略。一种新的半月板整体修复的体外模型将被用于这些研究，该模型由两个同心的半月板外植体组成，在体外培养数周后自然表现出修复。IL-1对细胞增殖、细胞迁移、胶原和蛋白多糖合成、基质金属蛋白酶活性以及胶原和蛋白多糖降解的影响将被确定。在IL-1存在的情况下，合成代谢因子和MMPs的抑制剂将被用来识别和阻断IL-1活性的机制，从而阻止半月板的整体修复。在IL-1存在或不存在的情况下，也将评估不同大小的机械应力对半月板撕裂修复的影响。这项研究的广泛和长期目标是确定IL-1活性的下游靶点，这些靶点可以是药理学和/或机械性靶点，从而最终可能在临床上有用，以促进损伤后和关节炎患者的半月板愈合。这项建议与公众健康相关，因为结果将对关节损伤或关节炎患者半月板损伤的新药物和物理治疗方法产生影响。已确定的潜在药物和机械治疗最终可能被转化为未来半月板修复的临床治疗方法。

DESCRIPTION (provided by applicant): The menisci are fibrocartilaginous tissues situated between the femoral condyles and the tibial plateau. These structures are essential for normal biomechanical function of the knee, including load bearing, shock absorption, joint congruity, and joint stability. In addition to the pain and disability with the initial meniscal injury, damage or loss of meniscal tissue is associated with degenerative changes in the joint that ultimately lead to osteoarthritis (OA). Increased levels of the inflammatory cytokines, such as interleukin-1 (IL-1), have been measured in injured and degenerative joints. In addition, IL-1 has been shown to upregulate degradatiye enzymes, such as matrix metalloproteinases (MMPs), and also decrease matrix biosynthesis by meniscal cells. IL-1 has also been shown to significantly decrease repair strength, cell accumulation, and tissue formation at the interface in a meniscal repair model system. However, the mechanism(s) by which IL-1 inhibits repair of meniscal lesions is not yet known. The goals of this study are to identify the mechanism(s) by which IL-1 prevents the repair of meniscal lesions and to develop strategies to enhance the healing of meniscal tears in presence of IL-1. A novel in vitro model of integrative repair of the meniscus that consists of two concentric meniscus explants that naturally exhibit repair over several weeks of culture in vitro will be utilized for these studies. The effects of IL-1 on cell proliferation, cell migration, collagen and proteoglycan synthesis, MMP activity, and collagen and proteoglycan degradation will be determined. In the presence of IL-1, anabolic factors and inhibitors of MMPs will be used to identify and block the mechanisms of IL-1 activity that prevent integrative repair of the meniscus. The effects of different magnitudes of mechanical stress on the repair of a meniscal tear in the presence or absence of IL-1 will also be assessed. The broad, long-term objectives of this study are to identify downstream targets of IL-1 activity that could be targeted pharmacologically and/or mechanically and thus could ultimately be useful clinically to promote meniscal healing following injury and in patients with arthritis. This proposal is relevant to public health, as results will have implications with regard to both novel pharmacologic and physical therapy treatments for meniscus injury in patients with a joint injury or arthritis. Potential pharmacologic and mechanical treatments identified could ultimately be translated clinically to future treatments for meniscus repair.